10th annual Immuno-Oncology Summit
Over the past 10 years, CHI’s Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 3-day program and extensive networking opportunities that CHI’s IO Summit provides.
This year’s immuno oncology summit offers several tracks, including bispecific antibodies for cancer immunotherapy, preclinical and translational immuno-oncology, and combination immunotherapies for cancer. Biocytogen’s products and services, especially our multigenic humanized models, can be useful tools to accelerate the discovery and development of novel anti-human immnunotherapies for improved clinical translation.
Biocytogen’s preclinical pharmacology team, which includes a dedicated in vitro team, can offer a range of expert support in study design and execution using these models. We look forward to discussing your next project!
(Source: Immuno-Oncology Summit)